DPI Research

The global influenza vaccines market size was valued at USD 7.8 Billion in 2023 and is likely to reach USD 13.7 Billion in 2032, expanding at a CAGR 7.2% during the forecast period.

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033

This growth is expected to continue, with projections indicating that the market could reach around US$ 9.66 billion by 2033, representing a compound annual growth rate (CAGR) of approximately 8% from 2025 – 2033.

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 - 2033

Market dynamics indicate a continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033

Market dynamics indicate continued expansion in the NIPT sector, with forecasts suggesting that the market could reach approximately US$ 2.8 billion by 2033 representing a compound annual growth rate (CAGR) of approximately 10.5% from 2025 – 2033.

The non-invasive prenatal testing (NIPT) market in the United States has experienced remarkable growth over recent years, reflecting an increasing awareness and acceptance of advanced prenatal screening technologies.

The influenza vaccines market in the United States has experienced significant growth in recent years, driven by various factors including heightened public awareness of infectious diseases and the ongoing innovations in vaccine technology.

The United States Influenza Vaccines market size was valued at USD 4.78 Billion in 2024 and is expected to grow USD 9.66 Billion in 2033 at a compound annual growth rate (CAGR) of 8% from 2025 to 2033.

As per DPI Research latest published report, the China-Non Invasive Prenatal Testing (NIPT) market size was valued at US$ 608 Million in 2023 and it is forecasted to reach US$ 1,083 Million by the year end of 2032.